| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.03 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |